Why does Tyro3 deficiency not affect neuroinvasive viral susceptibility unlike Mertk/Axl?

OPEN

The selective vulnerability associated with Mertk/Axl but not Tyro3 deficiency suggests distinct functional roles among TAM receptors in BBB integrity. This functional divergence within the TAM family lacks mechanistic explanation. Gap type: unexplained_observation Source paper: The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity. (2015, Nature medicine, PMID:26523970)

Priority: 0.76 Domain: neuroinflammation Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: Why does Tyro3 deficiency not affect neuroinvasive viral susceptibility unlike Mertk/Axl? is a 0.76 priority gap in neuroinflammation. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

Why does Tyro3 deficiency not affect neuroinvasive viral susceptibility unlike Mertk/Axl? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

No knowledge graph edges recorded

🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps